Adam Schiffenbauer

Dr. Adam Schiffenbauer

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2020 in JCI Insight
Verified
Journal Article
Open access
PDF file
NSNickie Seto
Nickie Seto
JTJose Jiram Torres-Ruiz
Jose Jiram Torres-Ruiz
CCCarmelo Carmona-Rivera
Carmelo Carmona-Rivera
IPIago Pinal-Fernandez
Iago Pinal-Fernandez
KPKatherine Pak
Katherine Pak
MKMariana J. Kaplan
Mariana J. Kaplan
Idiopathic inflammatory myopathies (IIM) are characterized by muscle inflammation and weakness, myositis-specific autoantibodies (MSAs), and extramuscular organ damage. The role of neutrophil dysregulation and neutrophil extracellular traps (NETs) in IIM is unclear. We assessed whether pathogenic neutrophil subsets (low-density granulocytes [LDGs]) and NETs were elevated in IIM, associated with clinical presentation and MSAs, and their effect on skeletal myoblasts and myotubes. Circulating NETs and LDGs were quantified and correlated with clinical measures. Specific MSAs were tested for their ability to induce NETs. NETs and neutrophil gene expression were measured in IIM biopsies. Whether NETs damage skeletal myoblasts and myotubes was tested. Circulating LDGs and NETs were increased in IIM. IIM LDGs had an enhanced ability to form NETs. LDGs and NETs correlated with IIM disease activity and muscle damage. The serum MSA anti-MDA5 correlated with circulating and tissue NETs and directly enhanced NET formation. An enhanced neutrophil gene signature was present in IIM muscle and associated with muscle injury and tissue IFN gene signatures. IIM NETs decreased the viability of myotubes in a citrullinated histone-dependent manner. Dysregulated neutrophil pathways may play pathogenic roles in IIM through their ability to directly injure muscle cells and other affected tissues.

1 June 2018 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
ASAdam Schiffenbauer
Adam Schiffenbauer
MGMegha Garg
Megha Garg
CCChristine Castro
Christine Castro
APAngelina Pokrovnichka
Angelina Pokrovnichka
GJGalen Joe
Galen Joe
MGMark Gourley
Mark Gourley

17 December 2024 in Arthritis & Rheumatology
Verified
Journal Article
Open access
SFSara Faghihi‐Kashani
Sara Faghihi‐Kashani
AYAkira Yoshida
Akira Yoshida
FBFrancisca Bozan
Francisca Bozan
Giovanni ZanframundoGiovanni Zanframundo
Giovanni Zanframundo
DRDavide Rozza
Davide Rozza
TIthe Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators
the Classification Criteria for Anti‐Synthetase Syndrome Project participating investigators
Objective: Anti‐synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data‐driven classification criteria for ASSD.Methods: We used a large, international, multicenter “Classification Criteria for Anti‐synthetase Syndrome” (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort.Results: Our analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo‐1 and non–Jo‐1 anti‐synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti‐Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD.Conclusion: We identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data‐driven classification criteria for ASSD. image

15 April 2006 in Journal of Virology
Verified
Journal Article
Closed access
BPBrian D. Poole
Brian D. Poole
JZJing Zhou
Jing Zhou
AGAmy Grote
Amy Grote
ASAdam Schiffenbauer
Adam Schiffenbauer
SNStanley J. Naides
Stanley J. Naides
Parvovirus B19 has been implicated in some cases of acute fulminant non-A, non-B, non-C, non-G liver failure. Our laboratory previously demonstrated that B19 infection of hepatocytes induces apoptosis and that the B19 viral nonstructural protein, NS1, may play a critical role. To study the involvement of NS1 in apoptosis of liver cells, we generated a fusion protein of NS1 with enhanced green fluorescent protein (eGFP) in a system allowing for inducible gene expression. Transfection of the liver-derived cell line HepG2 with the eGFP/NS1 vector allowed expression of the fusion protein, which was visualized by fluorescence microscopy and demonstrated by immunoblotting. The fusion protein localized to discrete domains in the nucleus. Transfection of HepG2 cells with the eGFP/NS1 vector led to apoptosis of 35% of transfected cells, a sevenfold increase over cells transfected with the parent eGFP expression vector. Mutation of the eGFP/NS1 vector to eliminate the nucleoside triphosphate-binding site of NS1 significantly decreased apoptosis, as did treatment of transfected cells with inhibitors of caspase 3 or 9. Neutralization of tumor necrosis factor alpha or Fas ligand had no effect on apoptosis. These results demonstrate that NS1 is sufficient to induce apoptosis in liver-derived cells and that it does so through the initiation of an intrinsic caspase pathway.

29 September 2008 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
TOTerrance P. O'Hanlon
Terrance P. O'Hanlon
LRLisa Rider
Lisa Rider
ASAdam Schiffenbauer
Adam Schiffenbauer
ITIra N. Targoff
Ira N. Targoff
KMKaren Malley
Karen Malley
FMFrederick W. Miller
Frederick W. Miller
Objective: To investigate possible associations of GM and KM markers with adult and juvenile forms of the idiopathic inflammatory myopathies (IIMs) in Caucasian and African American patients.Methods: We performed serologic analyses of polymorphic determinants associated with immunoglobulin gamma heavy chains (GM) and kappa light chains (KM) in large populations of Caucasian patients (n= 514 [297 adults and 217 children]) and African American patients (n = 123 [73 adults and 50 children]) with IIM representing the major clinical and autoantibody groups.Results: For Caucasian patients with dermatomyositis (DM), the Gm 3 23 5,13 phenotype was a risk factor in both adults (odds ratio [OR] 2.2, corrected P [Pcorr] = 0.020) and children (OR 2.2, Pcorr = 0.0013). Of interest, the GM 13 allotype was a risk factor for juvenile DM in both Caucasian subjects (OR 3.9, Pcorr < 0.0001) and African American subjects (OR 4.8, Pcorr = 0.033). However, the Gm 1,3,17 5,13,21 phenotype was a risk factor for juvenile DM in Caucasian subjects but not African American subjects. Among the IIM autoantibody groups, Gm 3 23 5,13 was a risk factor in Caucasian adults with anti–Jo‐1 autoantibodies (OR 3.4, Pcorr = 0.0031), while the GM 3 allotype was protective in adults with anti–threonyl–transfer RNA synthetase or anti–U RNP autoantibodies (OR 0.1, Pcorr = 0.047 and OR 0.2, Pcorr = 0.034, respectively). In contrast, GM 6 was a risk factor in African American adults with anti–signal recognition particle autoantibodies (OR 7.5, Pcorr = 0.041).Conclusion: These data suggest that polymorphic alleles of GM and KM loci are differentially associated with IIM subgroups defined by age, ethnicity, clinical features, and autoantibody status, and expand the list of immune response genes that are possibly important in the pathogenesis of myositis.

1 December 2018 in Seminars in Arthritis and Rheumatism
Verified
Journal Article
Closed access
ASAdam Schiffenbauer
Adam Schiffenbauer
SFSara Faghihi-Kashani
Sara Faghihi-Kashani
TOTerrence P. O'Hanlon
Terrence P. O'Hanlon
WFWilly A. Flegel
Willy A. Flegel
SASharon D. Adams
Sharon D. Adams
FMFrederick W. Miller
Frederick W. Miller